foscarnet has been researched along with Hyperphosphatemia in 5 studies
Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.
Hyperphosphatemia: A condition of abnormally high level of PHOSPHATES in the blood, usually significantly above the normal range of 0.84-1.58 mmol per liter of serum.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This is the first study demonstrating ornithine a key molecule mediating hyperphosphatemia-induced apoptosis of ECs." | 7.83 | Ornithine is a key mediator in hyperphosphatemia-mediated human umbilical vein endothelial cell apoptosis: Insights gained from metabolomics. ( Kang, X; Liu, JY; Mohan, C; Peng, A; Tang, B; Wu, T; Zhou, R, 2016) |
| "This is the first study demonstrating ornithine a key molecule mediating hyperphosphatemia-induced apoptosis of ECs." | 3.83 | Ornithine is a key mediator in hyperphosphatemia-mediated human umbilical vein endothelial cell apoptosis: Insights gained from metabolomics. ( Kang, X; Liu, JY; Mohan, C; Peng, A; Tang, B; Wu, T; Zhou, R, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, M | 1 |
| Zhang, Q | 1 |
| Zhang, M | 1 |
| Jiang, X | 1 |
| Wang, M | 1 |
| Ni, L | 1 |
| Gong, W | 1 |
| Huang, B | 1 |
| Chen, J | 1 |
| Hsu, YJ | 1 |
| Hsu, SC | 1 |
| Huang, SM | 1 |
| Lee, HS | 1 |
| Lin, SH | 1 |
| Tsai, CS | 1 |
| Shih, CC | 1 |
| Lin, CY | 1 |
| Zhou, R | 1 |
| Kang, X | 1 |
| Tang, B | 1 |
| Mohan, C | 1 |
| Wu, T | 1 |
| Peng, A | 1 |
| Liu, JY | 1 |
| Miyamoto, K | 1 |
| Segawa, H | 1 |
| Ito, M | 1 |
| Kuwahata, M | 1 |
| Zeng, M | 1 |
| Wang, X | 2 |
| Zhao, X | 1 |
1 review available for foscarnet and Hyperphosphatemia
| Article | Year |
|---|---|
[Progress in the identification of intestinal Pi transport inhibitors].
Topics: Animals; Antiviral Agents; Chronic Disease; Drug Design; Foscarnet; Humans; Hyperphosphatemia; Kidne | 2009 |
4 other studies available for foscarnet and Hyperphosphatemia
| Article | Year |
|---|---|
Phosphate Overload Stimulates Inflammatory Reaction via PiT-1 and Induces Vascular Calcification in Uremia.
Topics: Cells, Cultured; Cross-Sectional Studies; Female; Foscarnet; Humans; Hyperphosphatemia; Leukocytes, | 2022 |
Hyperphosphatemia induces protective autophagy in endothelial cells through the inhibition of Akt/mTOR signaling.
Topics: Adenine; Animals; Autophagy; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; En | 2015 |
Ornithine is a key mediator in hyperphosphatemia-mediated human umbilical vein endothelial cell apoptosis: Insights gained from metabolomics.
Topics: Apoptosis; Arginase; Arginine; Foscarnet; Human Umbilical Vein Endothelial Cells; Humans; Hyperphosp | 2016 |
Effects of phosphonoformic acid and renagel on renal type IIa sodium-dependent phosphate cotransporter mRNA expression in hyperphosphatemia rats.
Topics: Animals; Chelating Agents; Disease Models, Animal; Follow-Up Studies; Foscarnet; Gene Expression Reg | 2012 |